- Home
- PRDO vs WGSWW Comparison
PRDO vs WGSWW Comparison
Compare PRDO & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRDO
- WGSWW
- Stock Information
- Founded
- PRDO 1994
- WGSWW 2017
- Country
- PRDO United States
- WGSWW United States
- Employees
- PRDO N/A
- WGSWW 1000
- Industry
- PRDO Other Consumer Services
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- PRDO Real Estate
- WGSWW Technology
- Exchange
- PRDO Nasdaq
- WGSWW Nasdaq
- Market Cap
- PRDO N/A
- WGSWW N/A
- IPO Year
- PRDO N/A
- WGSWW N/A
- Fundamental
- Price
- PRDO $32.18
- WGSWW $0.03
- Analyst Decision
- PRDO Buy
- WGSWW
- Analyst Count
- PRDO 1
- WGSWW 0
- Target Price
- PRDO $40.00
- WGSWW N/A
- AVG Volume (30 Days)
- PRDO 645.9K
- WGSWW 36.6K
- Earning Date
- PRDO 07-30-2025
- WGSWW 02-18-2025
- Dividend Yield
- PRDO 1.62%
- WGSWW N/A
- EPS Growth
- PRDO N/A
- WGSWW N/A
- EPS
- PRDO 2.25
- WGSWW N/A
- Revenue
- PRDO $726,003,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- PRDO $24.62
- WGSWW N/A
- Revenue Next Year
- PRDO $3.83
- WGSWW N/A
- P/E Ratio
- PRDO $14.30
- WGSWW N/A
- Revenue Growth
- PRDO 6.35
- WGSWW 50.79
- 52 Week Low
- PRDO $20.23
- WGSWW $0.17
- 52 Week High
- PRDO $34.60
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- PRDO 56.29
- WGSWW N/A
- Support Level
- PRDO $31.29
- WGSWW N/A
- Resistance Level
- PRDO $32.65
- WGSWW N/A
- Average True Range (ATR)
- PRDO 0.86
- WGSWW 0.00
- MACD
- PRDO -0.28
- WGSWW 0.00
- Stochastic Oscillator
- PRDO 30.06
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.